Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Watson

Showing results (191-200 of 240) with videos related to

Pageof 24
Sort By:
The New England Journal of Medicine|March 14, 2008
Effect of herpes simplex suppression on incidence of HIV among women in TanzaniaDeborah Watson-Jones, Helen A Weiss, Mary Rusizoka, et al.
American Journal of Medical Genetics. Part A|October 16, 2021
A novel MBTPS2 variant associated with BRESHECK syndrome impairs sterol-regulated transcription and the endoplasmic reticulum stress responseAlanna Strong, Michael E March, Christopher J Cardinale, et al.
Plos One|July 6, 2022
Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocolsFrank Baiden, Suzanne Fleck, Bailah Leigh, et al.
Global Public Health|October 3, 2023
Continuity and Rupture in Crisis: from Ebola to COVID-19 in Sierra Leone and the eastern Democratic Republic of the CongoMyfanwy James, Anthony Mansaray, Frederic Omega Thige, et al.
The Journal of Infectious Diseases|December 18, 2012
Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine: a randomized trial in 10-25-year-old HIV-Seronegative African girls and young womenPapa Salif Sow, Deborah Watson-Jones, Nancy Kiviat, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 31, 2023
Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal studyBolarinde J Lawal, Katherine E Gallagher, Jonathan Kitonsa, et al.
Plos Medicine|February 28, 2018
Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studiesElizabeth A Torrone, Charles S Morrison, Pai-Lien Chen, et al.
Plos Medicine|June 27, 2018
Correction: Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studiesElizabeth A Torrone, Charles S Morrison, Pai-Lien Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccinesEdouard Lhomme, Aurélie Wiedemann, Ahidjo Ayouba, et al.
Vaccines|February 24, 2024
Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational StudyAdeep Puri, Andrew J Pollard, Catherine Schmidt-Mutter, et al.
Pageof 24

Showing results (191-200 of 240) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|March 14, 2008
Effect of herpes simplex suppression on incidence of HIV among women in TanzaniaDeborah Watson-Jones, Helen A Weiss, Mary Rusizoka, et al.
American Journal of Medical Genetics. Part A|October 16, 2021
A novel MBTPS2 variant associated with BRESHECK syndrome impairs sterol-regulated transcription and the endoplasmic reticulum stress responseAlanna Strong, Michael E March, Christopher J Cardinale, et al.
Plos One|July 6, 2022
Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocolsFrank Baiden, Suzanne Fleck, Bailah Leigh, et al.
Global Public Health|October 3, 2023
Continuity and Rupture in Crisis: from Ebola to COVID-19 in Sierra Leone and the eastern Democratic Republic of the CongoMyfanwy James, Anthony Mansaray, Frederic Omega Thige, et al.
The Journal of Infectious Diseases|December 18, 2012
Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine: a randomized trial in 10-25-year-old HIV-Seronegative African girls and young womenPapa Salif Sow, Deborah Watson-Jones, Nancy Kiviat, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 31, 2023
Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal studyBolarinde J Lawal, Katherine E Gallagher, Jonathan Kitonsa, et al.
Plos Medicine|February 28, 2018
Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studiesElizabeth A Torrone, Charles S Morrison, Pai-Lien Chen, et al.
Plos Medicine|June 27, 2018
Correction: Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studiesElizabeth A Torrone, Charles S Morrison, Pai-Lien Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccinesEdouard Lhomme, Aurélie Wiedemann, Ahidjo Ayouba, et al.
Vaccines|February 24, 2024
Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational StudyAdeep Puri, Andrew J Pollard, Catherine Schmidt-Mutter, et al.
Pageof 24